| # | Drug | Count |
|---|---|---|
| 0 | TOLVAPTAN | 204 |
| 1 | SODIUM CHLORIDE | 33 |
| 2 | SODIUM CHLORIDE TABLET | 28 |
| 3 | SODIUM CHLORIDE TABLETS | 28 |
| 4 | FUROSEMIDE | 14 |
| 5 | PANTOPRAZOLE SODIUM | 11 |
| 6 | BISOPROLOL FUMARATE | 9 |
| 7 | ETOPOSIDE | 9 |
| 8 | PANTOPRAZOLE | 9 |
| 9 | CARBOPLATIN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOLVAPTAN | 204 | 0.0137 |
| 1 | DEMECLOCYCLINE | 3 | 0.0132 |
| 2 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 3 | SALINE NASAL SPRAY | 6 | 0.0014 |
| 4 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 5 | SODIUM CHLORIDE | 33 | 0.0004 |
| 6 | APREPITANT | 3 | 0.0004 |
| 7 | CEFTAZIDIME | 3 | 0.0004 |
| 8 | SODIUM CHLORIDE TABLET | 28 | 0.0004 |
| 9 | SODIUM CHLORIDE TABLETS | 28 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 204 |
| 1 | Osmotic Laxative [EPC] | 28 |
| 2 | Loop Diuretic [EPC] | 15 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | Platinum-based Drug [EPC] | 10 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 6 | Topoisomerase Inhibitor [EPC] | 9 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 8 |
| 8 | Corticosteroid [EPC] | 8 |
| 9 | Benzodiazepine [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 204 | 0.0137 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | Typical Antipsychotic [EPC] | 3 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Osmotic Laxative [EPC] | 28 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 8 | 0.0001 |
| 9 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |